Orexo AB

International public company
PO Box 303, Uppsala,  S-751 05, Sweden
()46 018 780 88 00, 46 018 780 88 88 fax, http://www.orexo.com

Primary SIC: Medical Chemicals & Botanical Products, Primary NAICS: Medicinal and Botanical Manufacturing
Description: Manufacturing: Orexo is a pharmaceutical company with a focus on the therapeutic areas of pain and inflammation.The company develops new, patented drugs by combining well-documented substances with new technologies, and develops new treatments for respiratory and inflammatory diseases.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

Orexo AB, News and Information

Swedish Orexo 9-mo '09 revenue up, operating loss halves.
ADP News Nordic; 11/10/2009; 586 words; ...Swedish pharmaceutical company Orexo AB (STO:ORX) said today its...million in 2010. In August, Orexo said its Swedish partner Meda AB (STO:MEDA A) started the...USA. Later the same month, Orexo signed a licensing agreement...

Swedish Orexo revenue up, loss shrinks 9-mo '09.(Financial report)
Nordic Business Report; 11/10/2009; 629 words; ...Swedish pharmaceutical company Orexo AB (STO: ORX) said today its...SEK100m in 2010. In August, Orexo said its Swedish partner Meda AB (STO: MEDA A) started the...USA. Later the same month, Orexo signed a licensing agreement...

Endo Licenses Cancer Pain Product Rapinyl From Orexo.
BIOWORLD Today; 11/3/2009; 1161 words; ...market a product by the Swedish company Orexo AB, called Rapinyl, a sublingual mucoadhesive...of $10 million to Uppsala-based Orexo, which also could receive up to...payments. In addition, privately held Orexo is entitled to double-digit royalties...

Comprehsnsive Kyowa Hakko Report: Performance, Products, Pipeline and Potential.
M2 Presswire; 10/9/2009; 1211 words; ...MedImmune Inc - Merck & Co - Mitsubishi Tanabe Pharma Corporation - Novartis - OncoTherapy Science Inc - Orexo Pharmaceuticals AB - Sekisui Chemical - Takeda - UCB - Zeria Pharmaceutical For more information visit http://www.researchandmarkets...

Swedish Orexo receives "sell" recommendation from VA.
Nordic Business Report; 10/8/2009; 612 words; ...REPORT-8 October 2009-Swedish Orexo receives "sell" recommendation from...on Swedish pharmaceutical company Orexo AB (STO: ORX). It has turned out to be harder than expected for Orexo to achieve profitability, and now...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.